Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by tjw4on Aug 15, 2016 12:28am

144 Views

Post# 25141144

RE:RE:RE:RE:Insider stakes - the link

From what I have heard they are not looking for a buyout they are looking for an investor, which would mean the free float is very high which is my concern.

There are a lot of shares available for a penny stock. There appears to be a good 70% or 100mil+ of shares unaccounted for and that is unlikely to be held by retail investors. So it is either held by large institutions that are keeping under the radar or under the 10% reporting limit or they are not held at all.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario